Effects of increased sulfation of dermatan sulfate on its in vitro and in vivo pharmacological properties
- 1 October 1988
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 52 (2) , 153-164
- https://doi.org/10.1016/0049-3848(88)90094-1
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Increased sulphation improves the anticoagulant activities of heparan sulphate and dermatan sulphateBiochemical Journal, 1987
- Evidence for a saturable mechanism of disappearance of standard heparin in rabbitsThrombosis Research, 1987
- Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharidesBritish Journal of Haematology, 1986
- The haemorrhagic and antithrombotic effects of dermatan sulphateBritish Journal of Haematology, 1986
- CONSTITUTIONAL HEPARIN CO-FACTOR II DEFICIENCY ASSOCIATED WITH RECURRENT THROMBOSISThe Lancet, 1985
- Turnover Study of Heparin Cofactor II in Healthy ManThrombosis and Haemostasis, 1985
- Activation of heparin cofactor II by dermatan sulfate.Journal of Biological Chemistry, 1983
- Dermatan sulfate and heparin can be fractionated by affinity for heparin cofactor IIBiochemical and Biophysical Research Communications, 1983
- Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma.Journal of Biological Chemistry, 1982
- Catabolism of low-dose heparin in manThrombosis Research, 1979